Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02197572 · ClinicalTrials.gov registry record · Phase 1

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumors, sponsored by Calithera Biosciences.

Completed
Registry status
Phase 1
Development phase
44
Enrollment target
5
Study locations

NCT02197572 is a Phase 1 study of Advanced Solid Tumors that has completed, run by Calithera Biosciences. The registered enrollment target is 44 participants, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (78% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02197572, a Phase 1 study of Advanced Solid Tumors, has completed, sponsored by Calithera Biosciences.

COMPLETED
Registry status
Phase 1
Development phase
44 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to characterize the effect of a single dose of 40 mg sapanisertib (MLN0128) on the electrocardiographic QT/QTc interval in participants with advanced solid tumors.

Conditions Studied

Advanced Solid Tumors

Interventions

  • DRUG Sapanisertib

Study Locations (5)

Florida

  • - Sarasota

Missouri

  • - St Louis

New York

  • - The Bronx

Oklahoma

  • - Oklahoma City

Texas

  • - Dallas

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2014-09-15
Est. Completion 2019-02-28
Phase Phase 1

Sponsor

Calithera Biosciences

22 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02197572

The ClinicalTrials.gov registry entry for NCT02197572 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 144 other Advanced Solid Tumors trials with a reported enrollment target (78% lower). The listed sponsor is Calithera Biosciences, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which Sapanisertib is the first listed.

NCT02197572 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Missouri, New York.

Frequently Asked Questions

What is clinical trial NCT02197572 about?

NCT02197572 is a clinical study titled "Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors". The purpose of this study is to characterize the effect of a single dose of 40 mg sapanisertib (MLN0128) on the electrocardiographic QT/QTc interval in participants with advanced solid tumors.

What is the current status of trial NCT02197572?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2014-09-15. Estimated completion is 2019-02-28.

What conditions does trial NCT02197572 study?

This clinical trial studies the following conditions: Advanced Solid Tumors.

What interventions are being tested in trial NCT02197572?

The interventions under investigation include: Sapanisertib (DRUG).

Who is sponsoring clinical trial NCT02197572?

This trial is sponsored by Calithera Biosciences, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02197572 being conducted?

This trial has 5 study locations across Florida, Missouri, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumors

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.